Summit E2 by R. L. Williams Company Summit E2

Summit E2 by

Drug Labeling and Warnings

Summit E2 by is a Otc medication manufactured, distributed, or labeled by R. L. Williams Company. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SUMMIT E2- benzalkonium chloride soap 
R. L. Williams Company

----------

Summit E2

Active Ingredient

Benzalkonium Chloride 0.1%

Purpose

Skin Antimicrobial

Uses

• Reduces amount of bacteria on hands
• Recommended for repeated use

Warnings

For external use only.

When using this product, avoid contact with eyes.  In case of eye contact, flush eyes with water.

Stop use and ask a doctor if irritation or redness develops, or if condition persists for more than 72 hours.

Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Pump a small amount of foam into palm of hand.
• Rub thoroughly over all surfaces of both hands for at least fifteen seconds.
• Risne with potable water.

Inactive Ingredients

Water, Lauramine Oxide, Glycerin, PEG-120 Methyl Glucose Dioleate

SUMMIT E2 
benzalkonium chloride soap

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 23590-300
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	1 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
LAURAMINE OXIDE (UNII: 4F6FC4MI8W)
GLYCERIN (UNII: PDC6A3C0OX)
PEG-120 METHYL GLUCOSE DIOLEATE (UNII: YM0K64F20V)

Product Characteristics
Color	white (colorless, water-white (dispensed as a white foam))	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 23590-300-10	850 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	03/01/2021	07/31/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	03/01/2021	07/31/2025

Labeler - R. L. Williams Company (099976362)

Revised: 12/2023

Document Id: 0d19fbbd-6fd3-2e63-e063-6294a90a1e4a

34390-5

Set id: dec25905-5b08-4866-a2a5-4c60409761fc

Version: 4

Effective Time: 20231222